Short page
BPC-157/TB-500

Specification
| Name | BPC-157/TB-500 |
|---|---|
| Catalog sizes | 10 mg/10 mg |
| Adopted bacteriostatic water | 20 mg + 2.0 mL = 10 mg/mL |
Overview
The label states BPC-157 and TB-500 at 10 mg / 10 mg (20 mg total). TRACE has not published a trial of that blend. The page stays with the labeled mass, the adopted reconstitution, and the literature on each name separately.
Mechanism under study
See the BPC-157 and TB-500 pages for the setting of each peptide. This page does not add those settings into a mechanism for the blend.
What published research has reported
No clinical trial of the 10 mg / 10 mg blend is cited. References for the components are on their own pages.
This version does not close a study list. No citation is invented.
Composition and mass
20 mg total on the label (10 mg / 10 mg). Adopted bacteriostatic water: 2 mL (10 mg/mL of the total). If the split is half and half, each part sits at 5 mg/mL.
Reconstitution
| mg | mL | mg/mL | |
|---|---|---|---|
| 20 | 2.0 | 10 | In the catalog |
Storage and handling
Lyophilized material cool, dry, and protected from light. Dissolved: 2–8 °C, not frozen, 28-day horizon.
Regulatory status
Research material. Not an approved medicine.